Latest News

laboratory with researchers
Samsung Bioepis’ Stelara Biosimilar Proves Successful in Phase 1 Study

March 20th 2023

At the American Academy of Dermatology annual meeting, Samsung Bioepis shared positive results from a phase 1 study comparing its ustekinumab biosimilars (SB17) with the reference product (Stealara).

pregnant woman
Retrospective Study Supports Safety of Anti-TNF Biosimilars During Pregnancy

March 18th 2023

CVS health logo on a phone | Image credit: Игорь Головнёв -
CVS Predicts Interchangeability Won’t Drive Adalimumab Biosimilar Adoption

March 15th 2023

eye on pharma banner
Eye on Pharma: FDA, EMA Accept Biosimilar Applications; Biosimilar Trials Begin

March 9th 2023

doctor holding patient's hand
Report: Over 60% of Providers Plan to Only Prescribe Interchangeable Adalimumab Biosimilars

February 23rd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.